ECPG vs PFE · P/E 6.3, rev $1.32B vs P/E 20, rev $62.58B
Encore Capital Group Inc (ECPG) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Encore Capital Group Inc (ECPG) is a credit services company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ECPG revenue for 2024-12-31 was $1.32B. Net income was -$139.2M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. ECPG currently screens at market cap $1.73B and trailing P/E 6.3.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ECPG currently screens at market cap $1.73B and trailing P/E 6.3. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ECPG and PFE stock pages for the full models.
Not investment advice.